Springer - Applications of Antisense Therapies to Restenosis

Restenosis remains a significant challenge in cardiology, affecting up to 40% of the 500,000 patients who undergo angioplasty annually. This condition involves the proliferation of smooth muscle cells (SMC) that line blood vessels, often occurring after medical procedures. Applications of Antisense Therapies to Restenosis, part of the Perspectives in Antisense Science series, serves as a primary resource for understanding how antisense therapies can inhibit this process. This volume is the first to specifically address the potential of these therapies to prevent restenosis following percutaneous transluminal angioplasty and coronary stenting. By providing a critical examination of various antisense applications, this work offers valuable insights for medical professionals and researchers focused on cardiovascular health and internal medicine. It addresses a vital gap in current cardiology knowledge by exploring innovative methods to manage vessel regrowth and improve patient outcomes after vascular interventions.